Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Recent patents describe new treatment options for immunological disorders

Sep. 8, 2008

ProtAffin granted FDA orphan drug designation for PA-401 in transplantation

Sep. 8, 2008

YSPSL safe in phase I/II study in renal transplant patients

Sep. 5, 2008

New immunmodulatory agents disclosed by Otsuka Chemical

Sep. 4, 2008

Characterization of Pfizer's novel CP-690550 in de novo kidney transplant patients

Sep. 4, 2008

GSK withdraws European MAA for Quintanrix vaccine

Sep. 3, 2008

Novel JAK-3 inhibitor active as immunosuppressant in trachea transplanted rats

Sep. 3, 2008

Novel agents for transplant rejection described in recent patents

Sep. 2, 2008

Studies report efficacy of alternative regimens of enteric-coated mycophenolate in transplantation

Aug. 28, 2008

Durable safety and efficacy seen with belatacept in phase II study

Aug. 28, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...